# Larimar Therapeutics, Inc.: Form SC 13D/A, filed Mar 17, 2023

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: SC 13D/A
- Filed: 2023-03-17
- Accepted by EDGAR: Mar 16, 2023, 17:41 ET
- Period: not reported
- Accession: 0001193805-23-000345
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119380523000345/e618373_sc13da-lt.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119380523000345/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119380523000345/e618373_sc13da-lt.htm

Filed Mar 17, 2023.
Source: SEC EDGAR, the filing index for accession 0001193805-23-000345. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
